| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.796 | 12.928 | 17.421 | 15.921 | 40.938 | 65.104 |
| Total Income - EUR | - | - | - | - | 4.796 | 12.928 | 17.464 | 15.921 | 40.938 | 65.104 |
| Total Expenses - EUR | - | - | - | - | 213 | 753 | 2.306 | 858 | 11.442 | 11.244 |
| Gross Profit/Loss - EUR | - | - | - | - | 4.584 | 12.175 | 15.158 | 15.063 | 29.495 | 53.860 |
| Net Profit/Loss - EUR | - | - | - | - | 4.440 | 11.799 | 14.634 | 14.656 | 29.147 | 51.946 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Roxymedical Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 17 | 1.672 | 978 | 417 | 1.518 | 813 |
| Current Assets | - | - | - | - | 4.578 | 14.665 | 14.963 | 15.486 | 37.533 | 69.549 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 1.043 | 973 | 12.001 | 3.858 | 34.478 | 36.281 |
| Cash | - | - | - | - | 1.428 | 4.389 | 2.962 | 11.629 | 3.055 | 33.268 |
| Shareholders Funds | - | - | - | - | 4.482 | 16.195 | 14.703 | 14.719 | 32.138 | 51.994 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 113 | 142 | 1.238 | 1.184 | 6.913 | 18.368 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Roxymedical Plus S.r.l.